Dalfopristin; quinupristin - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dalfopristin; quinupristin and what is the scope of patent protection?
Dalfopristin; quinupristin
is the generic ingredient in one branded drug marketed by King Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for dalfopristin; quinupristin
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | dalfopristin; quinupristin at DailyMed |
Recent Clinical Trials for dalfopristin; quinupristin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mount Sinai Hospital, Canada | Phase 2 |
US Patents and Regulatory Information for dalfopristin; quinupristin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | SYNERCID | dalfopristin; quinupristin | INJECTABLE;INTRAVENOUS | 050748-001 | Sep 21, 1999 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | SYNERCID | dalfopristin; quinupristin | INJECTABLE;INTRAVENOUS | 050748-002 | Aug 24, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |